Cronos Group Inc. - Common Share (CRON) Social Stream
CRONOS GROUP INC (CRON) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRON.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 8 | $12.5 | $5.54 | $8.255 | $2.09 | 294.98% |
| 2021-11-29 | 9 | $12.5 | $5 | $7.782 | $2.09 | 272.34% |
| 2022-01-27 | 9 | $12.5 | $3.24 | $7.526 | $2.09 | 260.1% |
| 2022-02-21 | 9 | $9 | $3.24 | $5.467 | $2.09 | 161.58% |
| 2022-02-23 | 9 | $8 | $3.24 | $4.905 | $2.09 | 134.69% |
| 2022-02-24 | 8 | $8 | $3.24 | $4.905 | $2.09 | 134.69% |
| 2022-03-02 | 8 | $5.5 | $3.24 | $4.462 | $2.09 | 113.49% |
| 2022-03-03 | 7 | $5.5 | $3.24 | $4.248 | $2.09 | 103.25% |
| 2022-03-06 | 7 | $5.5 | $3 | $4.105 | $2.09 | 96.41% |
| 2022-03-21 | 7 | $5.5 | $2.9 | $4.057 | $2.09 | 94.11% |
| 2022-05-01 | 6 | $5.5 | $2.9 | $4.233 | $2.09 | 102.54% |
| 2022-05-09 | 6 | $6 | $2.9 | $4.4 | $2.09 | 110.53% |
| 2022-05-10 | 8 | $6 | $2.9 | $4.4 | $2.09 | 110.53% |
| 2022-05-12 | 8 | $6 | $3 | $4.254 | $2.09 | 103.54% |
| 2022-05-17 | 9 | $6 | $3 | $4.254 | $2.09 | 103.54% |
| 2022-07-26 | 9 | $6 | $3 | $4.225 | $2.09 | 102.15% |
| 2022-07-29 | 9 | $7 | $3 | $4.43 | $2.09 | 111.96% |
| 2022-08-10 | 9 | $7 | $3 | $4.344 | $2.09 | 107.85% |
| 2022-09-17 | 9 | $7 | $3 | $4.307 | $2.09 | 106.08% |
| 2022-10-24 | 9 | $7 | $3 | $4.021 | $2.09 | 92.39% |
| 2022-10-25 | 9 | $7 | $2.7 | $3.978 | $2.09 | 90.33% |
| 2022-11-07 | 10 | $7 | $3 | $3.862 | $2.09 | 84.78% |
| 2022-11-09 | 13 | $7 | $2.5 | $3.68 | $2.09 | 76.08% |
| 2022-12-16 | 13 | $7 | $2.5 | $3.76 | $2.09 | 79.9% |
| 2023-01-09 | 13 | $7 | $2.5 | $3.71 | $2.09 | 77.51% |
| 2023-01-26 | 13 | $7 | $2.7 | $3.706 | $2.09 | 77.32% |
| 2023-01-27 | 13 | $7 | $2.5 | $3.688 | $2.09 | 76.46% |
| 2023-02-28 | 13 | $7 | $2.3 | $3.67 | $2.09 | 75.6% |
| 2023-03-02 | 13 | $5.25 | $2.1 | $3.204 | $2.09 | 53.3% |
| 2023-05-09 | 11 | $3.75 | $2.1 | $3.042 | $2.09 | 45.55% |
| 2023-05-10 | 11 | $3.75 | $1.8 | $2.999 | $2.09 | 43.49% |
| 2023-05-15 | 11 | $3.5 | $1.8 | $2.899 | $2.09 | 38.71% |
| 2023-05-18 | 12 | $3.72 | $1.8 | $2.853 | $2.09 | 36.51% |
| 2023-06-06 | 12 | $3.72 | $1.5 | $2.828 | $2.09 | 35.31% |
| 2023-06-22 | 12 | $3.72 | $1.5 | $2.8 | $2.09 | 33.97% |
| 2023-08-08 | 11 | $3.72 | $1.5 | $2.782 | $2.09 | 33.11% |
| 2023-08-10 | 11 | $3.72 | $1.5 | $2.769 | $2.09 | 32.49% |
| 2023-08-16 | 11 | $3.72 | $1.5 | $2.764 | $2.09 | 32.25% |
| 2023-09-01 | 11 | $3.69 | $1.5 | $2.761 | $2.09 | 32.11% |
| 2023-09-18 | 9 | $3.69 | $1.8 | $2.562 | $2.09 | 22.58% |
| 2023-10-31 | 9 | $3.69 | $1.5 | $2.576 | $2.09 | 23.25% |
| 2023-11-09 | 9 | $3.69 | $1.7 | $2.551 | $2.09 | 22.06% |
| 2023-11-10 | 9 | $3.69 | $1.5 | $2.529 | $2.09 | 21% |
The Trend in the Analyst Price Target
Over the past 38 weeks, CRON's average price target has gone down $1.14.
Over the past 47 weeks, CRON's average upside potential has been 44.45%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-15 | 11 | 3.42 | 1.8 | 2.775 | 1.76 | 57.67% |
| 2023-05-15 | 11 | 3.50 | 1.8 | 2.899 | 1.76 | 64.72% |
| 2023-05-18 | 12 | 3.72 | 1.8 | 2.853 | 1.82 | 56.76% |
| 2023-06-22 | 11 | 3.72 | 1.5 | 2.782 | 1.90 | 46.42% |
| 2023-08-10 | 11 | 3.72 | 1.5 | 2.769 | 1.75 | 58.23% |
CRON Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.44 | 3 | 0 | 5 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 45 months, CRON's average broker recommendation rating improved by 0.03.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRON as an investment opportunity.
- CRONOS GROUP INC's average analyst price target is higher than 141.52% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CRONOS GROUP INC's variance in analysts' estimates is lower than -4311.59% of them.
- CRON has a greater number of analysts covering the stock than 3804.75% of stocks in the mid market cap category.
- In terms of how CRONOS GROUP INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1685.73% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CRONOS GROUP INC are USNA, LNTH, and RIOT.
View All Top Stocks by Price Target
Make investment decisions regarding CRON using the data that counts. Try POWR Ratings for free.